Skip to content

ESTA

Establishment Labs Holdings Inc.

NASDAQ · CRHealthcareMedical - Devices
$93.42+0.91%

Price as of Jul 20, 2026

ESTA growth

Establishment Labs Holdings Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+34.9%
EBITDA
+75.0%
EBIT
+50.8%
EPS
+52.5%
Free cash flow
+44.9%
Operating cash flow
+48.9%

Forward estimates

Revenue
+28.4%
EBITDA
EPS
+54.7%

Three-year CAGR

Revenue
+9.3%
EBITDA
+60.4%
EBIT
+22.0%
Net income
+39.6%
EPS
+42.7%
Free cash flow
+22.2%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.